Dutrebis União Europeia - inglês - EMA (European Medicines Agency)

dutrebis

merck sharp dohme limited - lamivudine, raltegravir potassium - hiv infections - antivirals for systemic use, antivirals for treatment of hiv infections, combinations - dutrebis is indicated in combination with other anti‑retroviral medicinal products for the treatment of human immunodeficiency virus (hiv‑1) infection in adults, adolescents, and children from the age of 6 years and weighing at least 30 kg without present or past evidence of viral resistance to antiviral agents of the insti (integrase strand transfer inhibitor) and nrti (nucleoside reverse transcriptase inhibitor) classes (see sections 4.2, 4.4 and 5.1).

Symtuza União Europeia - inglês - EMA (European Medicines Agency)

symtuza

janssen-cilag international nv - darunavir, cobicistat, emtricitabine, tenofovir alafenamide - hiv infections - antivirals for systemic use, antivirals for treatment of hiv infections, combinations - symtuza is indicated for the treatment of human immunodeficiency virus type 1 (hiv‑1) infection in adults and adolescents (aged 12 years and older with body weight at least 40 kg).genotypic testing should guide the use of symtuza.

ActiViral Austrália - inglês - Department of Health (Therapeutic Goods Administration)

activiral

mcpherson's consumer products pty ltd - ascorbic acid,andrographis paniculata,echinacea purpurea,lonicera japonica,olea europaea,zinc glycinate -

Activiral Austrália - inglês - Department of Health (Therapeutic Goods Administration)

activiral

mcpherson's consumer products pty ltd - ascorbic acid, quantity: 250 mg; zinc glycinate, quantity: 26.1 mg (equivalent: zinc, qty 8 mg); olea europaea, quantity: 125 mg (equivalent: olea europaea, qty 1.25 g); lonicera japonica, quantity: 100 mg (equivalent: lonicera japonica, qty 1 g); echinacea purpurea, quantity: 125 mg (equivalent: echinacea purpurea, qty 750 mg); andrographis paniculata, quantity: 200 mg - capsule, hard - excipient ingredients: colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; maltodextrin; calcium carbonate; hypromellose; disodium edetate; potable water; potassium acetate; gellan gum - maintain/support healthy immune system function ; maintain/support immune system to fight illness ; decrease/reduce/relieve symptoms of common colds and flu (linked indication:relieve weariness/tiredness/fatigue/feeling of weakness; antipyretic/febrifuge/relieve mild fever/reduce body temperature/body cooling; decrease/reduce/relieve disturbed/restless sleep; decrease/reduce/relieve cough; relieve runny/dripping nose); decrease/reduce/relieve the severity of symptoms of mild upper respiratory tract infections (linked indication:relieve weariness/tiredness/fatigue/feeling of weakness; antipyretic/febrifuge/relieve mild fever/reduce body temperature/body cooling; decrease/reduce/relieve disturbed/restless sleep; decrease/reduce/relieve cough; relieve runny/dripping nose); relieve symptoms of sore throat/pharyngitis

Activiral Austrália - inglês - Department of Health (Therapeutic Goods Administration)

activiral

mcpherson's consumer products pty ltd - ascorbic acid, quantity: 250 mg; olea europaea, quantity: 125 mg (equivalent: olea europaea, qty 1.25 g); lonicera japonica, quantity: 100 mg (equivalent: lonicera japonica, qty 1 g); echinacea purpurea, quantity: 125 mg (equivalent: echinacea purpurea, qty 750 mg); zinc glycinate monohydrate, quantity: 28.32 mg (equivalent: zinc, qty 8 mg); andrographis paniculata, quantity: 200 mg (equivalent: andrographolide (of andrographis paniculata), qty 70 mg; equivalent: andrographis paniculata, qty 2800 mg) - capsule, hard - excipient ingredients: colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; maltodextrin; hypromellose; calcium carbonate - maintain/support healthy immune system function ; maintain/support immune system to fight illness ; decrease/reduce/relieve symptoms of common colds and flu (linked indication:relieve weariness/tiredness/fatigue/feeling of weakness; antipyretic/febrifuge/relieve mild fever/reduce body temperature/body cooling; decrease/reduce/relieve disturbed/restless sleep; decrease/reduce/relieve cough; relieve runny/dripping nose); decrease/reduce/relieve the severity of symptoms of mild upper respiratory tract infections (linked indication:relieve weariness/tiredness/fatigue/feeling of weakness; antipyretic/febrifuge/relieve mild fever/reduce body temperature/body cooling; decrease/reduce/relieve disturbed/restless sleep; decrease/reduce/relieve cough; relieve runny/dripping nose); relieve symptoms of sore throat/pharyngitis

Lamivudine Teva União Europeia - inglês - EMA (European Medicines Agency)

lamivudine teva

teva b.v. - lamivudine - hepatitis b, chronic - antivirals for systemic use - lamivudine teva is indicated for the treatment of chronic hepatitis b in adults with:compensated liver disease with evidence of active viral replication, persistently elevated serum alanine aminotransferase (alt) levels and histological evidence of active liver inflammation and / or fibrosis. initiation of lamivudine treatment should only be considered when the use of an alternative antiviral agent with a higher genetic barrier is not available or appropriate (see in section 5.1).

Zeffix União Europeia - inglês - EMA (European Medicines Agency)

zeffix

glaxosmithkline (ireland) limited - lamivudine - hepatitis b, chronic - antivirals for systemic use - zeffix is indicated for the treatment of chronic hepatitis b in adults with: , compensated liver disease with evidence of active viral replication, persistently elevated serum alanine aminotransferase (alt) levels and histological evidence of active liver inflammation and / or fibrosis. initiation of lamivudine treatment should only be considered when the use of an alternative antiviral agent with a higher genetic barrier is not available or appropriate;, decompensated liver disease in combination with a second agent without cross-resistance to lamivudine.

Prevymis União Europeia - inglês - EMA (European Medicines Agency)

prevymis

merck sharp & dohme b.v. - letermovir - cytomegalovirus infections - antivirals for systemic use - prevymis is indicated for prophylaxis of cytomegalovirus (cmv) reactivation and disease in adult cmv-seropositive recipients [r+] of an allogeneic haematopoietic stem cell transplant (hsct).consideration should be given to official guidance on the appropriate use of antiviral agents.

COFIX RX- povidone-iodine antiviral nasal spray liquid Estados Unidos - inglês - NLM (National Library of Medicine)

cofix rx- povidone-iodine antiviral nasal spray liquid

cofix-rx llc - povidone-iodine (unii: 85h0hzu99m) (iodine - unii:9679tc07x4) - antiviral antiviral to temporarily prevent viral infection and transmission ■ if allergic to iodine or inactive ingredient(s) ■ in the eyes ■ on children less than 3 years old stop use and ask a doctor if symptoms persist or worsen ■ swelling, infection, rash, or fever occurs

Maxidex Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

maxidex

novartis new zealand ltd - dexamethasone 1 mg/g (3% overage is applied during manufacture);   - eye ointment - 0.1 % - active: dexamethasone 1 mg/g (3% overage is applied during manufacture)   excipient: lanolin oil methyl hydroxybenzoate propyl hydroxybenzoate white soft paraffin